(2025). The activity of pyrazoline B compound in inhibiting proliferation of breast cancer cells with human epidermal growth factor receptor 2 overexpression. Contemporary Oncology / Współczesna Onkologia, 29(4), 1. https://doi.org/10.5114/wo.2025.155694
Chicago Style (17th ed.) Citation"The Activity of Pyrazoline B Compound in Inhibiting Proliferation of Breast Cancer Cells with Human Epidermal Growth Factor Receptor 2 Overexpression." Contemporary Oncology / Współczesna Onkologia 29, no. 4 (2025): 1. https://doi.org/10.5114/wo.2025.155694.
MLA (9th ed.) Citation"The Activity of Pyrazoline B Compound in Inhibiting Proliferation of Breast Cancer Cells with Human Epidermal Growth Factor Receptor 2 Overexpression." Contemporary Oncology / Współczesna Onkologia, vol. 29, no. 4, 2025, p. 1, https://doi.org/10.5114/wo.2025.155694.
